Biliary Tract Diseases, Liver Diseases, Pancreatic Diseases
Conditions
Keywords
Three-Dimensional Image, Three Dimensional Printing
Brief summary
Background:The aim of the study is to value the application of three-dimensional visualization and three-dimensional printing in the hepatobiliary and pancreatic surgery.Method：From January 2016 to December 2018,the clinical data of 200 patients with the hepatobiliary and pancreatic diseases will be collected.All the patients received abdominal CT scanning and 3D reconstruction. Then we used the 3D reconstruction model and the 3D printed model based on the 3D reconstruction model in the operation planning and the operation.The clinical data include operative time, intraoperative blood loss,and postoperative complications after surgery.
Detailed description
From January 2016 to December 2018,the clinical data of 200 patients with the hepatobiliary and pancreatic diseases will be collected.All the patients received abdominal CT scanning and 3D reconstruction. Then we used the 3D reconstruction model and the 3D printed model based on the 3D reconstruction model in the operation planning and the operation.The clinical data include operative time, intraoperative blood loss,and postoperative complications after surgery.
Interventions
OTHER3D visualization and 3D printing
From January 2016 to December 2018,the clinical data of 200 patients with the hepatobiliary and pancreatic diseases will be collected.All the patients received abdominal CT scanning and 3D reconstruction. Then we used the 3D reconstruction model and the 3D printed model based on the 3D reconstruction model in the operation planning and the operation.The clinical data include operative time, intraoperative blood loss,and postoperative complications after surgery.
Sponsors
Zhujiang Hospital
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* the hepatobiliary and pancreatic diseases
Exclusion criteria
* none of the hepatobiliary and pancreatic diseases
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| operative time | 1 year | operative time |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| intraoperative blood loss | 1 year | intraoperative blood loss |
| postoperative complications after surgery | 1 year | postoperative complications after surgery |
Countries
China
Contacts
Primary ContactChihua Fang, MD
Backup ContactNan Xiang, MD
Outcome results
None listed